Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Olink Proteomics AB

Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to participate in September investor events
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink reports second quarter 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Announcing Olink® Explore HT – A New Era in Proteomics
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to participate in June investor events
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink reports first quarter 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to report first quarter 2023 financial results on May 11, 2023
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Swedish Olink technology enables further development of South African research and innovation
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink publishes 2022 annual report
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Bruno Rossi joins Olink as Chief Commercial Officer
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discovery
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink reports fourth quarter and full year 2022 financial results
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink Holding AB (publ) launches public offering of American Depositary Shares
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to participate in the 41st Annual JP Morgan Healthcare Conference
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink reports third quarter 2022 financial results
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to participate in November investor events
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Announcing Olink® Insight, a digital knowledge-sharing platform to amplify the value of proteomics data
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Olink to report third quarter 2022 financial results on November 10, 2022
From Olink Proteomics AB
Via GlobeNewswire
Tickers OLK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.